Changes Associated With the Entry of a Biosimilar in the Insulin Glargine Market
Joseph Levy, Zahra M. Chowdhury, Mariana P. Socal, Antonio J. Trujillo
Abstract
This study explores the shifts in total US sales and net prices for all 3 insulin glargine products from quarter 1 of 2010 through quarter 2 of 2020.
Topics & Concepts
MedicineBiosimilarInsulin glargineInsulinInternal medicinePharmacologyHypoglycemiaBiosimilars and Bioanalytical MethodsPharmaceutical Economics and Policy